Acrivon Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-14.0M | $-14.2M | $238.0K | $497.0K |
| FY2022 | $-30.1M | $-32.3M | $2.2M | $2.2M |
| FY2023 | $-42.6M | $-43.9M | $1.3M | $11.6M |
| FY2024 | $-65.7M | $-68.4M | $2.8M | $14.3M |
| FY2025 | $-63.7M | $-65.3M | $1.7M | $14.7M |